BUY Aurobindo Pharma — Motilal Oswal, 03 Dec 2025

BUYAurobindo Pharma

Aurobindo Pharma share price target & all analyst calls

byMotilal OswalHorizon: NA (inferred 1 year)3 Dec 2025via Institutional / Brokerage Research

Entry₹1,208.9Inferred

Target₹1,430

Total upside +18.29%

Stop lossNot given

Exit₹1,43023 Apr 2026, 12:04 pm

Target hit+18.29%0.00%upside left

Follow Motilal Oswal for new calls(62% target hit, 1113 closed calls)Get alerts Watch AUROPHARMA for new buy/sell callsGet alerts See 11 active Long-term calls on AUROPHARMA See 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 4:41 pm IST

3 supporting2 neutral0 opposing

Supports the BUY call (3)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·6 Apr · 2w ago

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·1 Apr · 3w ago

Neutral / worth noting (2)

Aurobindo Pharma Ltd submitted a Letter of Offer for the buyback of 5,423,728 fully paid-up equity shares.

BSE · Company Update·21 Apr · yesterday

Upcoming Stock Split, Dividend, Bonus Issue THIS Week: Aurobindo Pharma, Muthoot Finance, More | Full List

NewsGoogle News·12 Apr · 1w ago

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Motilal Oswal

Every call and its outcome